Newsletter from Hamlet Biopharma
Hamlet Biopharma An innovative pharmaceutical company with a wide and robust portfolio ofprojects for the treatment of cancer and infections. Cancer A central goal of cancer therapy is to selectively target the tumor andminimize toxicity for healthy tissue. Hamlet Biopharma is developing newtherapeutic solutions for targeting and killing tumor cells with greaterprecision. Alpha1H is one of Hamlet Biopharma’s main drug candidates. Alpha1His a synthetically manufactured peptide in complex with oleic acid and anefficient anti-tumor drug candidate for the